Hydralazine / Isosorbide Dinitrate Oral Tablet [Bidil]
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
In 2005 the FDA approved BiDil, the first drug ever to include a race-specific indication on its label - to treat heart failure…
rappelle l’édifiante histoire du BiDil, l’association d’isosorbide dinitrate et d’hydralazine (I/H) pour le traitement de l…
When the US Food and Drug Administration licensed the drug BiDil® in June 2005 it was hailed as a significant step towards…
BiDil® (hydralazine and isosorbide dinitrate) represents an interesting application of personalized medicine - the first…
903 Illuminating BiDil BiDil is a recently approved therapy indicated for congestive heart failure patients already taking…